SPRING PHARMACEUTICAL GROUP, INC.: key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2017)

$64.9M

Net Income/Loss (FY2017)

$11.7M

Total Assets (FY2017)

$110.1M

Total Equity (FY2017)

$108.2M

Cash Flows from Operating Activities (FY2017)

$17.9M

Source: SPRING PHARMACEUTICAL GROUP, INC. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.